Several organizations are developing new Ebola vaccines in response to growing concern about a current outbreak of a rare Ebola species. New Zimbabwe and BBC News report that the International AIDS Vaccine Initiative (IAVI) is working on one vaccine and says the outbreak could become the worst on record. BBC News adds that the vaccine development work involves multiple teams, including IAVI, Moderna and the University of Oxford. The Reuters/BBC-style details shared across the two summaries indicate these groups are conducting research and developing vaccine candidates rather than describing deployed products.
New Zimbabwe also states that the outbreak has already killed nearly 250 people and describes it as a threat that is intensifying. Taken together, the coverage highlights parallel efforts by major research and pharmaceutical organizations to create vaccine options that can be used against the specific Ebola strain currently causing concern. The reports do not specify when the vaccines will be ready or whether any are already in widespread use, focusing instead on ongoing development efforts and the seriousness of the outbreak.
